China’s biotech surge sparks US security concerns as drug trials break records in 2025 (opens in new tab)

Clinical drug trial registrations in China hit a record last year, the country’s drug regulator said, with more than 5,000 trials reported in the latest sign of the nation’s growing pipeline of novel drug candidates. The total number of clinical drug trials reached 5,215 in 2025, more than double the figure recorded in 2020, according to a report released by the National Medical Products Administration on Monday. Of those, 57.5 per cent were trials for new drugs, an 18 per cent year-on-year...